Skip to content

TDCS in Acute Stroke

Safety Study of Transcranial Direct Current Stimulation in Aphasia Therapy in Acute and Post-acute Stroke

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01701713
Acronym
TDCS-aphasia
Enrollment
100
Registered
2012-10-05
Start date
2009-06-30
Completion date
2013-06-30
Last updated
2012-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

TDCS, STROKE, APHASIA, NAMING

Brief summary

The purpose of this study is to determine the safety of transcranial direct current stimulation in aphasia therapy in acute and post-acute stroke.

Detailed description

TDCS has been shown to have a positive effect on clinical outcome in both motor rehabilitation and aphasia treatment in chronic aphasic patients. In healthy subjects the method sped up reaction times in naming and language learning tasks. In TDCS a weak current is applied to the subjects head increasing excitatory activity which might lead to improved brain function.

Interventions

DEVICEDKI ED2011
DEVICESham-TDCS

Sponsors

German Federal Ministry of Education and Research
CollaboratorOTHER_GOV
Brandenburg Klinik, Bernau, Germany
CollaboratorUNKNOWN
University of Potsdam
CollaboratorOTHER
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* first media stroke * language impairment * informed consent * right handedness * NIHSS \< 20

Exclusion criteria

* previous Epilepsy oder epileptogenic events * epilepsy typical elements in EEG * hypersensitive skin (head) * metal implants (head) * pace maker or other electronic implants * previous head/brain surgery * medication reducing seizure threshold * previous psychiatric events

Design outcomes

Primary

MeasureTime frame
skin irritation2 months

Secondary

MeasureTime frameDescription
Improved language2 monthsimproved picture naming

Countries

Germany

Contacts

Primary ContactGerhard J Jungehuelsing, MD
jan.jungehuelsing@charite.de
Backup ContactIsabell Wartenburger, Prof. MD
isabell.wartenburger@uni-potsdam.de

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026